1997
DOI: 10.1016/s0940-2993(97)80053-x
|View full text |Cite
|
Sign up to set email alerts
|

Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats — protective effects of Cerebrolysin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
6
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 25 publications
1
6
0
Order By: Relevance
“…It is believed to increase neuronal viability and survival during and after ischemic events. [27][28][29][30][31][32] Cerebrolysin reduces the amyloid formation as well as the average size of amyloid plaques in Alzheimer's disease, which is accompanied by an improvement of the behavioural phenotype and increase of synaptic density. Significant improvements in cognitive enhancement and daily activities have been reported recently for Alzheimer patients.…”
Section: Neuron Stimulants Used In This Studymentioning
confidence: 99%
“…It is believed to increase neuronal viability and survival during and after ischemic events. [27][28][29][30][31][32] Cerebrolysin reduces the amyloid formation as well as the average size of amyloid plaques in Alzheimer's disease, which is accompanied by an improvement of the behavioural phenotype and increase of synaptic density. Significant improvements in cognitive enhancement and daily activities have been reported recently for Alzheimer patients.…”
Section: Neuron Stimulants Used In This Studymentioning
confidence: 99%
“…Cere shows neuroprotective activity and neurotrophic function increasing neuronal survival after different types of lesions in vitro and in animals models of neurodegeneration [2,3], moreover, it promotes neuritic outgrowth and cholinergic fibres regeneration [4,5]. Cere has been used for the treatment of dementia and sequel of stroke and improves memory in patients with mild to moderate cognitive impairment [6,7].…”
mentioning
confidence: 99%
“…The multimodal agent Cerebrolysin (Cere) (Ever Neuro Pharma GmbH, Oberburgau, Austria) consists of approximately 25% low molecular weight biologically active peptides, which are actually active fragments of some important neurotrophic factors (CNTF, GDNF, IGF-1, IGF-2) [1] and 75% free amino acids obtained by enzymatic breakdown of purified porcine brain proteins. Cere shows neuroprotective activity and neurotrophic function increasing neuronal survival after different types of lesions in vitro and in animals models of neurodegeneration [2,3], moreover, it promotes neuritic outgrowth and cholinergic fibres regeneration [4,5]. Cere has been used for the treatment of dementia and sequel of stroke and improves memory in patients with mild to moderate cognitive impairment [6,7].…”
mentioning
confidence: 99%
“…The neurotropic action of Cerebrolysine has now been studied in clinical conditions and by experimental physiologists [13,27,39,40]. This preparation is a mixture of free amino acids (85%) and peptides (15%).…”
Section: Discussionmentioning
confidence: 99%